Bold Capital
Facts
- HQ
- Santa Monica, California, US
- Sectors
- Venture Capital and Private Equity Principals
- Employees
- 19
Viome’s Full Body Intelligence Test Discounted to $299 for Amazon Prime Day with Advanced Gut Health Analysis
Viome’s Full Body Intelligence test, offering detailed gut microbiome analysis and personalized food and supplement recommendations, is discounted by $100 during Amazon Prime Day. The test requires at-home collection of blood, saliva, and stool samples and provides comprehensive health insights using advanced RNA sequencing technology.
Viome Raises $25M, Hires Ex-Amazon Exec Kal Raman as COO to Expand CancerDetect Diagnostic
Viome, a microbiome and health diagnostics startup, raised $25 million and hired former Amazon senior VP Kal Raman as COO to expand its diagnostic division. The company’s CancerDetect test for oral and throat cancer, granted FDA breakthrough device status, exhibits high sensitivity and specificity.
Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores
Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.
Seattle Startup Proprio Raises $43M Series B After FDA Clears Paradigm Surgical Navigation Platform
Seattle startup Proprio raised $43 million in a Series B round after receiving FDA 510(k) clearance for its Paradigm surgical navigation platform, which provides real-time 3D visualization for clinicians. The system integrates advanced imaging technologies and is preparing for human use this summer.
Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests
Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.
Viome Raises $67 Million in Latest Funding Round to Expand Microbiome and Diagnostic Testing
Seattle-based microbiome startup Viome Life Sciences has raised $67 million in a new funding round, bringing its total funding to over $125 million. The company offers stool, saliva, and blood testing kits for personalized health insights and is developing an FDA-designated diagnostic test for oral and throat cancer.
Viome raises $54M to develop saliva-based cancer diagnostics and expand microbiome consumer business
Viome Life Sciences raised $54 million to advance cancer diagnostics and support its consumer microbiome testing and customized supplement business, bringing total funding to over $125 million while targeting $100M revenue and one million customers next year.
Proprio raises $23M Series A led by DCVC to commercialize 3D "X‑ray‑like" surgical navigation system
Seattle startup Proprio raised $23 million in a Series A led by DCVC to develop a hardware‑software surgical navigation system that fuses real-time camera views with preoperative imaging to give surgeons a 3D “X‑ray‑like” view without radiation.
